Panel recommends opposite hormone therapy

<p>NEW YORK (Reuters Health) Women holding hormone therapy to forestall certain chronic conditions or palliate prohibited flashes face a difficult brew of probable advantages and risks, a new investigate of past investigate suggests.
The analysis, published Monday in a Annals of Internal Medicine, combines a formula of 9 prior clinical trials and found that women holding estrogen or a multiple of estrogen and progestin lowered their risk of damaged bones, though increasing their chances of building a horde of other complications, including strokes and gallbladder disease.
Taken together, estrogen and progestin also seemed to boost a risk of breast cancer and insanity nonetheless estrogen alone was tied to fewer breast cancer cases.
Based on a new analysis, a government-backed U.S. Preventive Services Task Force (USPSTF) released rough recommendations on Tuesday that postmenopausal women not use hormone therapy to forestall certain ongoi...